nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—Melatonin—NQO2—Parkinson's disease	0.0771	1	CrCbGaD
Nabumetone—MPO—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00881	0.00955	CbGpPWpGaD
Nabumetone—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00873	0.00946	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—INS—Parkinson's disease	0.00814	0.00882	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00813	0.00881	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00805	0.00872	CbGpPWpGaD
Nabumetone—CYP1A2—Xenobiotics—CYP2D6—Parkinson's disease	0.00798	0.00865	CbGpPWpGaD
Nabumetone—CYP1A2—Estrogen metabolism—NQO1—Parkinson's disease	0.00786	0.00851	CbGpPWpGaD
Nabumetone—CYP1A2—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00768	0.00832	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.00747	0.00809	CbGpPWpGaD
Nabumetone—CYP1A2—Xenobiotics—CYP2E1—Parkinson's disease	0.0073	0.00791	CbGpPWpGaD
Nabumetone—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—Parkinson's disease	0.00715	0.00775	CbGpPWpGaD
Nabumetone—CYP1A2—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00702	0.00761	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—TNF—Parkinson's disease	0.007	0.00759	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—Parkinson's disease	0.00675	0.00732	CbGpPWpGaD
Nabumetone—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.00658	0.00713	CbGpPWpGaD
Nabumetone—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.00656	0.0071	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00655	0.0071	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—INS—Parkinson's disease	0.00647	0.00701	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL1B—Parkinson's disease	0.00608	0.00658	CbGpPWpGaD
Nabumetone—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.00602	0.00652	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00598	0.00648	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00598	0.00648	CbGpPWpGaD
Nabumetone—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00593	0.00643	CbGpPWpGaD
Nabumetone—PTGS1—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00567	0.00614	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL6—Parkinson's disease	0.00565	0.00612	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—GDNF—Parkinson's disease	0.00563	0.0061	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—MAG—Parkinson's disease	0.00563	0.0061	CbGpPWpGaD
Nabumetone—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.00552	0.00598	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00547	0.00593	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.00542	0.00587	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—VIM—Parkinson's disease	0.00529	0.00574	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—PDYN—Parkinson's disease	0.00515	0.00558	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—TNF—Parkinson's disease	0.00489	0.00529	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—GFAP—Parkinson's disease	0.00484	0.00525	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00483	0.00523	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—GSTA4—Parkinson's disease	0.0048	0.0052	CbGpPWpGaD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00478	0.00518	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—INSR—Parkinson's disease	0.00475	0.00515	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—PLA2G6—Parkinson's disease	0.00464	0.00502	CbGpPWpGaD
Nabumetone—PTGS1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.0045	0.00488	CbGpPWpGaD
Nabumetone—PTGS2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.0045	0.00488	CbGpPWpGaD
Nabumetone—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00446	0.00484	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—HSPA8—Parkinson's disease	0.00441	0.00478	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—TNF—Parkinson's disease	0.00441	0.00478	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.00437	0.00474	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—Parkinson's disease	0.00437	0.00473	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—MAOB—Parkinson's disease	0.00428	0.00463	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.0042	0.00455	CbGpPWpGaD
Nabumetone—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00416	0.00451	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—IL6—Parkinson's disease	0.00394	0.00427	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—TNF—Parkinson's disease	0.00388	0.0042	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00378	0.0041	CbGpPWpGaD
Nabumetone—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00375	0.00406	CbGpPWpGaD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00373	0.00404	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00371	0.00402	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00371	0.00402	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.00368	0.00399	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00362	0.00392	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00361	0.00391	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL6—Parkinson's disease	0.00356	0.00385	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—TNF—Parkinson's disease	0.0035	0.00379	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00341	0.0037	CbGpPWpGaD
Nabumetone—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00338	0.00367	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00333	0.00361	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00333	0.00361	CbGpPWpGaD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00332	0.00359	CbGpPWpGaD
Nabumetone—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00327	0.00355	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—CYP2D6—Parkinson's disease	0.00318	0.00344	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—IL6—Parkinson's disease	0.00313	0.00339	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—GSTM1—Parkinson's disease	0.0031	0.00336	CbGpPWpGaD
Nabumetone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00303	0.00329	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.003	0.00325	CbGpPWpGaD
Nabumetone—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00299	0.00324	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—CYP2E1—Parkinson's disease	0.00291	0.00315	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00286	0.0031	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00283	0.00307	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00283	0.00306	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00269	0.00291	CbGpPWpGaD
Nabumetone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Parkinson's disease	0.00267	0.00289	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00266	0.00288	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—INS—Parkinson's disease	0.00265	0.00287	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00264	0.00286	CbGpPWpGaD
Nabumetone—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00255	0.00276	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—BDNF—Parkinson's disease	0.00248	0.00268	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—Parkinson's disease	0.00246	0.00266	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00246	0.00266	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—COMT—Parkinson's disease	0.00241	0.00261	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—GSTP1—Parkinson's disease	0.0024	0.0026	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—MAOA—Parkinson's disease	0.00239	0.00259	CbGpPWpGaD
Nabumetone—PTGS1—Biological oxidations—GSTM1—Parkinson's disease	0.0022	0.00239	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.00216	0.00234	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00213	0.0023	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00211	0.00229	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—INS—Parkinson's disease	0.0021	0.00228	CbGpPWpGaD
Nabumetone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00202	0.00219	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00198	0.00214	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.00192	0.00208	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00191	0.00207	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.00185	0.002	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.00184	0.00199	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Parkinson's disease	0.00179	0.00194	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00171	0.00185	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.00169	0.00183	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00168	0.00183	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00166	0.0018	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00166	0.0018	CbGpPWpGaD
Nabumetone—PTGS2—Disease—VPS35—Parkinson's disease	0.00159	0.00173	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00157	0.0017	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ND3—Parkinson's disease	0.00156	0.00169	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MCCC1—Parkinson's disease	0.00156	0.00169	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.0015	0.00162	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.00149	0.00162	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MCCC1—Parkinson's disease	0.00148	0.0016	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—OMD—Parkinson's disease	0.00147	0.00159	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TALDO1—Parkinson's disease	0.00147	0.00159	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00143	0.00155	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.00143	0.00155	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00141	0.00153	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NDUFB11—Parkinson's disease	0.00139	0.00151	CbGpPWpGaD
Nabumetone—PTGS2—Disease—OMD—Parkinson's disease	0.00139	0.00151	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TALDO1—Parkinson's disease	0.00139	0.00151	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GCH1—Parkinson's disease	0.00133	0.00144	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.00132	0.00143	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.00131	0.00141	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00129	0.0014	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1B—Parkinson's disease	0.00124	0.00134	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MCCC1—Parkinson's disease	0.00124	0.00134	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ND3—Parkinson's disease	0.00124	0.00134	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CASP3—Parkinson's disease	0.00124	0.00134	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.0012	0.0013	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00119	0.00129	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GBA—Parkinson's disease	0.00118	0.00128	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—FBP1—Parkinson's disease	0.00118	0.00128	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—DBH—Parkinson's disease	0.00118	0.00128	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TALDO1—Parkinson's disease	0.00117	0.00126	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—OMD—Parkinson's disease	0.00117	0.00126	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00116	0.00125	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00114	0.00123	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TAF1—Parkinson's disease	0.00112	0.00122	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FBP1—Parkinson's disease	0.00112	0.00122	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NDUFB11—Parkinson's disease	0.00111	0.0012	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.00108	0.00117	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.00108	0.00117	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00108	0.00117	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.00108	0.00117	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.00107	0.00116	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.00107	0.00116	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00106	0.00115	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GCH1—Parkinson's disease	0.00105	0.00114	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.00099	0.00107	CbGpPWpGaD
Nabumetone—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000976	0.00106	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000951	0.00103	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—FBP1—Parkinson's disease	0.00094	0.00102	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DBH—Parkinson's disease	0.00094	0.00102	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GBA—Parkinson's disease	0.00094	0.00102	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000918	0.000995	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—Parkinson's disease	0.0009	0.000975	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPL6—Parkinson's disease	0.000897	0.000972	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SNCA—Parkinson's disease	0.000897	0.000972	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—DDC—Parkinson's disease	0.000869	0.000941	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000842	0.000912	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.000821	0.000889	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00081	0.000878	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000773	0.000838	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000745	0.000807	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.000739	0.0008	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MAOB—Parkinson's disease	0.000731	0.000792	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	0.000726	0.000787	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000702	0.00076	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000702	0.00076	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000696	0.000754	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DDC—Parkinson's disease	0.00069	0.000747	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPL23A—Parkinson's disease	0.00068	0.000737	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPL14—Parkinson's disease	0.00068	0.000737	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.00066	0.000715	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—OMD—Parkinson's disease	0.00066	0.000715	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTA4—Parkinson's disease	0.000651	0.000706	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000643	0.000697	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF20—Parkinson's disease	0.000634	0.000687	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS8—Parkinson's disease	0.000634	0.000687	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000625	0.000678	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000612	0.000663	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.000597	0.000646	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLA2G6—Parkinson's disease	0.000586	0.000635	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MAOB—Parkinson's disease	0.000581	0.000629	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000553	0.000599	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.000544	0.000589	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000538	0.000583	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CTGF—Parkinson's disease	0.000534	0.000578	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000532	0.000576	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000532	0.000576	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000532	0.000576	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000497	0.000539	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000492	0.000533	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—TH—Parkinson's disease	0.000484	0.000525	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADRBK1—Parkinson's disease	0.000466	0.000505	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYCS—Parkinson's disease	0.000465	0.000504	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HSPA1A—Parkinson's disease	0.000463	0.000501	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2D6—Parkinson's disease	0.000431	0.000468	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CTGF—Parkinson's disease	0.000424	0.000459	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—COMT—Parkinson's disease	0.000412	0.000446	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTP1—Parkinson's disease	0.00041	0.000444	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MAOA—Parkinson's disease	0.000409	0.000443	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—Parkinson's disease	0.000404	0.000438	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2E1—Parkinson's disease	0.000395	0.000428	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DDC—Parkinson's disease	0.00039	0.000423	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NQO1—Parkinson's disease	0.00039	0.000423	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCB1—Parkinson's disease	0.000388	0.000421	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TH—Parkinson's disease	0.000385	0.000417	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—Parkinson's disease	0.000377	0.000408	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYCS—Parkinson's disease	0.000369	0.0004	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000369	0.000399	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000364	0.000394	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GPX1—Parkinson's disease	0.000361	0.000391	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—Parkinson's disease	0.000333	0.000361	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000332	0.00036	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000329	0.000356	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—COMT—Parkinson's disease	0.000327	0.000354	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTP1—Parkinson's disease	0.000325	0.000353	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MAOA—Parkinson's disease	0.000325	0.000352	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—Parkinson's disease	0.000321	0.000348	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—Parkinson's disease	0.000316	0.000342	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000313	0.000339	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOE—Parkinson's disease	0.00031	0.000336	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCB1—Parkinson's disease	0.000308	0.000334	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—Parkinson's disease	0.000299	0.000324	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOE—Parkinson's disease	0.000294	0.000318	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GPX1—Parkinson's disease	0.000286	0.00031	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—INS—Parkinson's disease	0.000265	0.000287	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—Parkinson's disease	0.000264	0.000286	CbGpPWpGaD
Nabumetone—PTGS2—Disease—INS—Parkinson's disease	0.000251	0.000272	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOE—Parkinson's disease	0.000246	0.000267	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000244	0.000265	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.00024	0.00026	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.000223	0.000242	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.000221	0.000239	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TH—Parkinson's disease	0.000218	0.000236	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—INS—Parkinson's disease	0.00021	0.000228	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYCS—Parkinson's disease	0.000209	0.000226	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—COMT—Parkinson's disease	0.000185	0.000201	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTP1—Parkinson's disease	0.000184	0.0002	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MAOA—Parkinson's disease	0.000184	0.000199	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—Parkinson's disease	0.000182	0.000197	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCB1—Parkinson's disease	0.000174	0.000189	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—Parkinson's disease	0.000169	0.000183	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX1—Parkinson's disease	0.000162	0.000176	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—Parkinson's disease	0.00015	0.000162	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOE—Parkinson's disease	0.000139	0.000151	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—INS—Parkinson's disease	0.000119	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—Parkinson's disease	0.00011	0.000119	CbGpPWpGaD
